POWELL MICHAEL
Insider CIK 1202793 · ALIM 10% owner · MRNS 10% owner · OCRX Director · KBIO 10% owner · ANTH 10% owner · AERI 10% owner · LIFE 10% owner · TSRX Director, 10% owner · HSGX 10% owner · HPTX 10% owner · PRNB 10% owner · VSAR 10% owner · MIRN Director, 10% owner · DRTX 10% owner · ACRS 10% owner · GRTX Director, 10% owner · BOLT 10% owner · CMPI Director, 10% owner · ITRM 10% owner · NXTC 10% owner · INZY 10% owner · AKUS 10% owner · ETTX 10% owner · VERA 10% owner · BCAX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 64,000 | — | $0 | 64,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 10,030 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 30,000 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 30,000 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | A Award deriv | 2021-08-09 | 2021-08-10 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 13,179 | — | $0 | 13,179 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | A Award deriv | 2021-06-16 | 2021-06-21 | 10,030 | — | $0 | 10,030 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion deriv | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2021-05-18 | 2021-05-18 | 727,272 | $11.00 | $8.00M | 2,914,776 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 2,187,504 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,200,228 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,104,209 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,200,228 | — | $0 | 2,304,437 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 450,000 | $20.00 | $9.00M | 2,754,437 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,104,209 | — | $0 | 1,104,209 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | A Award deriv | 2020-11-10 | 2020-11-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 12,500,000 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 8,753,350 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 3,644,624 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion | 2020-08-11 | 2020-08-12 | 3,473,374 | — | $0 | 3,473,374 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | P Buy | 2020-08-11 | 2020-08-12 | 133,333 | $15.00 | $2.00M | 3,606,707 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 11,888,112 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 1,590,808 | — | $0 | 1,590,808 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 437,500 | $16.00 | $7.00M | 2,028,308 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 12,643,557 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 18,044,028 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-01 | 58,823 | $17.00 | $1000.0K | 1,515,073 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 599,988 | — | $0 | 1,456,250 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 856,262 | — | $0 | 856,262 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-10 | 13,179 | — | $0 | 13,179 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2020-06-02 | 2020-06-03 | 400,000 | $1.61 | $644.0K | 1,226,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2020-06-01 | 2020-06-03 | 100,000 | $1.69 | $169.0K | 1,626,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 0 | $1750000.00 | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2019-11-15 | 2019-11-19 | 150,000 | $36.75 | $5.51M | 2,671,856 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 9,090,909 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 2,709,659 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-11-12 | 2019-11-12 | 750,000 | $12.00 | $9.00M | 3,083,712 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 2,333,712 | — | $0 | 2,333,712 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2019-11-06 | 2019-11-08 | 19,776 | — | $0 | 19,776 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2019-06-05 | 2019-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 3,773,585 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 7,301,000 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 3,732,500 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 2,239,500 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 464,599 | — | $0 | 743,358 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 908,785 | — | $0 | 1,652,143 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 469,713 | — | $0 | 2,121,856 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 278,759 | — | $0 | 278,759 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2019-05-13 | 2019-05-15 | 400,000 | $15.00 | $6.00M | 2,521,856 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 7,446,904 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 9,502,249 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 359,267 | — | $0 | 359,267 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | P Buy | 2018-09-28 | 2018-10-02 | 337,724 | $15.00 | $5.07M | 1,180,178 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 458,425 | — | $0 | 842,454 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 453,954 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 625,482 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 521,235 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 625,482 | — | $0 | 625,482 | SEC↗ |
| PRNB Principia Biopharma Inc. | P Buy | 2018-09-18 | 2018-09-20 | 270,000 | $17.00 | $4.59M | 2,038,208 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 1,768,208 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 453,954 | — | $0 | 1,600,671 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 521,235 | — | $0 | 1,146,717 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2018-06-13 | 2018-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 721,408 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 229,660 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 275,446 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 500,000 | $13.00 | $6.50M | 1,726,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 721,408 | — | $0 | 721,408 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 229,660 | — | $0 | 1,226,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 275,446 | — | $0 | 996,854 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2018-01-26 | 2018-01-30 | 150,000 | $9.75 | $1.46M | 574,972 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2017-12-29 | 2018-01-03 | 18,572 | — | $0 | 18,572 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2017-08-28 | 2017-08-30 | 1,428 | — | $0 | 1,428 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2016-10-31 | 2016-12-30 | 138,686 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2016-10-31 | 2016-12-30 | 9,540 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2016-10-31 | 2016-12-30 | 14,328 | — | $0 | 14,328 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2016-10-31 | 2016-12-30 | 699,996 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 724,788 | $1.39 | $1.01M | 1,134,851 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 12,528 | $1.39 | $17.4K | 15,470 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 13,367 | $1.39 | $18.6K | 224,845 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | X Exercise deriv | 2016-09-12 | 2016-12-30 | 1,820 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | X Exercise deriv | 2016-09-12 | 2016-12-30 | 1,820 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | X Exercise deriv | 2016-09-12 | 2016-12-30 | 9,187 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | X Exercise deriv | 2016-09-12 | 2016-12-30 | 125 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | X Exercise deriv | 2016-09-12 | 2016-12-30 | 125 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | X Exercise deriv | 2016-09-12 | 2016-12-30 | 9,187 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | X Exercise | 2016-09-12 | 2016-12-30 | 18,374 | $0.67 | $12.3K | 705,368 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | X Exercise | 2016-09-12 | 2016-12-30 | 3,640 | $0.67 | $2.4K | 139,752 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | S Sale | 2016-09-12 | 2016-12-30 | 74 | $2.29 | $169 | 9,540 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | S Sale | 2016-09-12 | 2016-12-30 | 1,066 | $2.29 | $2.4K | 138,686 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | S Sale | 2016-09-12 | 2016-12-30 | 5,372 | $2.29 | $12.3K | 699,996 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | X Exercise | 2016-09-12 | 2016-12-30 | 250 | $0.67 | $168 | 9,614 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | M Exercise deriv | 2016-07-11 | 2016-07-13 | 11,969 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | M Exercise | 2016-07-11 | 2016-07-13 | 11,969 | $1.26 | $15.1K | 11,969 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | A Award deriv | 2016-06-29 | 2016-09-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-06-14 | 2016-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,424,242 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,063,107 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,000,000 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2015-10-13 | 2015-10-13 | 409,090 | $11.00 | $4.50M | 2,289,480 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion | 2015-10-13 | 2015-10-13 | 1,880,390 | — | $0 | 1,880,390 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-06 | 289,841 | — | $0 | 2,117,669 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-06 | 857,142 | $7.00 | $6.00M | 2,974,811 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 1,244,269 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 1,827,828 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 1,244,269 | — | $0 | 1,244,269 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | A Award deriv | 2015-09-30 | 2015-09-30 | 7,200 | — | $0 | 7,200 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2015-06-18 | 2015-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 14,968,722 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 1,546,126 | — | $0 | 1,546,126 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2015-05-12 | 2015-05-14 | 320,000 | $14.00 | $4.48M | 1,866,126 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | U Tender | 2015-05-07 | 2015-05-08 | 1,939,474 | $46.00 | $89.22M | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | X Exercise deriv | 2014-12-08 | 2014-12-10 | 14,569 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion deriv | 2014-12-08 | 2014-12-10 | 960,345 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion deriv | 2014-12-08 | 2014-12-10 | 611,738 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion | 2014-12-08 | 2014-12-10 | 960,345 | — | $0 | 960,345 | SEC↗ |
| HSGX HISTOGENICS CORP | X Exercise | 2014-12-08 | 2014-12-10 | 14,569 | $0.76 | $11.1K | 1,586,652 | SEC↗ |
| HSGX HISTOGENICS CORP | S Sale | 2014-12-08 | 2014-12-10 | 1,002 | $11.00 | $11.0K | 1,585,650 | SEC↗ |
| HSGX HISTOGENICS CORP | P Buy | 2014-12-08 | 2014-12-10 | 500,198 | $11.00 | $5.50M | 2,085,848 | SEC↗ |
| HSGX HISTOGENICS CORP | J Other | 2014-12-08 | 2014-12-10 | 8,808 | — | $0 | 2,077,040 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion | 2014-12-08 | 2014-12-10 | 611,738 | — | $0 | 1,572,083 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | J Other | 2014-09-12 | 2014-09-15 | 2,000,000 | — | $0 | 506,270 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | J Other | 2014-09-12 | 2014-09-15 | 40,020 | — | $0 | 40,020 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion deriv | 2014-09-11 | 2014-09-15 | 166,667 | — | $0 | 83,333 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion | 2014-09-11 | 2014-09-15 | 2,506,270 | $2.66 | $6.67M | 2,506,270 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | J Other deriv | 2014-08-05 | 2014-08-07 | 524,734 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 28,156 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 636,393 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 2,065,553 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 28,612 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 415,857 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 2,098,937 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 43,785 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | J Other deriv | 2014-08-05 | 2014-08-07 | 103,964 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | J Other deriv | 2014-08-05 | 2014-08-07 | 7,153 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 3,212,038 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 409,241 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 494,161 | — | $0 | 494,161 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 6,736 | — | $0 | 6,736 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 322,913 | — | $0 | 817,074 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 63,978 | — | $0 | 161,885 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 4,402 | — | $0 | 11,138 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 317,777 | — | $0 | 1,134,851 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 62,960 | — | $0 | 224,845 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 4,332 | — | $0 | 15,470 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 724,788 | $8.00 | $5.80M | 1,859,639 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 13,367 | $8.00 | $106.9K | 238,212 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 12,528 | $8.00 | $100.2K | 27,998 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 97,907 | — | $0 | 97,907 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-07-10 | 2014-07-11 | 8,022 | $25.81 | $207.0K | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-07-09 | 2014-07-11 | 1,000,000 | $24.00 | $24.00M | 1,566,657 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-06-11 | 2014-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | S Sale | 2014-06-04 | 2014-06-06 | 417,747 | $27.70 | $11.57M | 1,939,474 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | J Other | 2014-06-02 | 2014-06-04 | 200,000 | — | $0 | 2,566,657 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | J Other | 2014-06-02 | 2014-06-04 | 8,022 | — | $0 | 8,022 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-05-22 | 2014-05-27 | 323,932 | $16.00 | $5.18M | 2,766,657 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 775,315 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 802,596 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 485,664 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 23,403 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 485,664 | — | $0 | 2,086,978 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2014-03-26 | 2014-03-28 | 60,000 | $21.00 | $1.26M | 2,146,978 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 23,403 | — | $0 | 23,403 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 775,315 | — | $0 | 798,718 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 802,596 | — | $0 | 1,601,314 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2014-03-18 | 2014-03-20 | 338,370 | — | $0 | 686,994 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2014-03-18 | 2014-03-20 | 67,040 | — | $0 | 136,112 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2014-03-18 | 2014-03-20 | 4,612 | — | $0 | 9,364 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | S Sale | 2014-03-04 | 2014-03-05 | 23,625 | $30.02 | $709.2K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other | 2014-03-03 | 2014-03-05 | 23,625 | — | $0 | 23,625 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other | 2014-03-03 | 2014-03-05 | 590,000 | — | $0 | 2,357,221 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 6,818,182 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 353,800 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 778,000 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 750,000 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 4,662,765 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-30 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2013-10-25 | 2013-10-30 | 285,000 | $10.00 | $2.85M | 3,090,589 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-30 | 932,553 | — | $0 | 932,553 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-30 | 1,363,636 | — | $0 | 2,296,189 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-30 | 353,800 | — | $0 | 2,805,589 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-30 | 155,600 | $0.05 | $7.8K | 2,451,789 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-08-30 | 2013-12-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 125 | — | $0 | 125 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 125 | — | $0 | 125 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 1,820 | — | $0 | 1,820 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 1,820 | — | $0 | 1,820 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 9,187 | — | $0 | 9,187 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 9,187 | — | $0 | 9,187 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 2,992 | — | $0 | 2,992 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 2,992 | — | $0 | 2,992 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 11,969 | — | $0 | 11,969 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2013-07-15 | 2013-07-17 | 9,576 | — | $0 | 9,576 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-17 | 63,957 | $6.03 | $385.7K | 203,152 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2013-07-15 | 2013-07-17 | 139,195 | — | $0 | 139,195 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-17 | 322,809 | $6.03 | $1.95M | 1,025,364 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2013-07-15 | 2013-07-17 | 702,555 | — | $0 | 702,555 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-17 | 4,400 | $6.03 | $26.5K | 13,976 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 2,565 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 3,143 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 210,056 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 1,675 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 9,982 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 653,356 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 19,120 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 5,231 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 341,236 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 11,226 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 2,851 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 185,996 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 6,118 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 1,207 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 80,731 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 643 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 1,367 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 171,450 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 11,226 | — | $0 | 20,517 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 341,236 | — | $0 | 901,437 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 5,231 | — | $0 | 13,683 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 19,120 | — | $0 | 39,637 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 653,356 | — | $0 | 1,554,793 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 1,392 | — | $0 | 31,415 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 93,129 | — | $0 | 2,072,914 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 742 | — | $0 | 43,767 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 2,918 | — | $0 | 30,023 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 195,088 | — | $0 | 1,979,785 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 1,555 | — | $0 | 43,025 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 3,440 | — | $0 | 27,105 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 229,904 | — | $0 | 1,784,697 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 2,851 | — | $0 | 8,452 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 185,996 | — | $0 | 560,201 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 6,118 | — | $0 | 9,291 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 1,833 | — | $0 | 41,470 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 9,982 | — | $0 | 23,665 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 0 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 0 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 2,043 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other deriv | 2012-07-31 | 2012-08-02 | 51,744 | $10.00 | $517.4K | 2,043 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 53,787 | — | $0 | 53,787 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 53,787 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 2,043 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other deriv | 2012-07-31 | 2012-08-02 | 51,744 | $10.00 | $517.4K | 2,043 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 53,787 | — | $0 | 53,787 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 53,787 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 125,291 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 898,808 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 0 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 611,185 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 434,096 | — | $0 | 2,026,281 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 898,808 | — | $0 | 1,513,927 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 611,185 | — | $0 | 615,119 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | P Buy | 2012-07-31 | 2012-08-02 | 563,000 | $10.00 | $5.63M | 2,947,221 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 177,481 | — | $0 | 2,384,221 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 180,459 | — | $0 | 2,206,740 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 2,043 | — | $0 | 1,592,185 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 2,043 | — | $0 | 1,590,142 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other | 2012-07-31 | 2012-08-02 | 51,119 | — | $0 | 1,588,099 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2012-07-31 | 2012-08-02 | 125,291 | — | $0 | 1,639,218 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion deriv | 2012-07-24 | 2012-07-25 | 1,683,094 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion | 2012-07-24 | 2012-07-25 | 1,683,094 | — | $0 | 1,683,094 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy | 2012-07-24 | 2012-07-25 | 588,236 | $9.00 | $5.29M | 2,271,330 | SEC↗ |
| TSRX Trius Therapeutics Inc | M Exercise deriv | 2012-03-26 | 2012-03-27 | 9,302 | — | $0 | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | M Exercise | 2012-03-26 | 2012-03-27 | 9,302 | $1.29 | $12.0K | 9,302 | SEC↗ |
| TSRX Trius Therapeutics Inc | S Sale | 2012-01-19 | 2012-01-20 | 2,600 | $5.64 | $14.7K | 113,100 | SEC↗ |
| TSRX Trius Therapeutics Inc | S Sale | 2012-01-18 | 2012-01-20 | 4,300 | $5.56 | $23.9K | 115,700 | SEC↗ |
| TSRX Trius Therapeutics Inc | S Sale | 2012-01-17 | 2012-01-17 | 16,100 | $5.43 | $87.4K | 120,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | S Sale | 2012-01-13 | 2012-01-17 | 8,522 | $5.46 | $46.5K | 136,100 | SEC↗ |
| TSRX Trius Therapeutics Inc | J Other | 2012-01-12 | 2012-01-17 | 144,622 | — | $0 | 144,622 | SEC↗ |
| TSRX Trius Therapeutics Inc | J Other | 2012-01-12 | 2012-01-17 | 3,615,572 | — | $0 | 28 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2011-12-30 | 2012-01-03 | 280 | $6.23 | $1.7K | 44,969 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2011-12-30 | 2012-01-03 | 4,090 | $6.23 | $25.5K | 653,550 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2011-12-30 | 2012-01-03 | 20,630 | $6.23 | $128.5K | 3,298,684 | SEC↗ |